|
|
|
Volumn 2, Issue 8, 2001, Pages 1093-1096
|
|
YM-337 Yamanouchi
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ABCIXIMAB;
FIBRINOGEN RECEPTOR ANTAGONIST;
MONOCLONAL ANTIBODY C4G1;
UNCLASSIFIED DRUG;
YM 337;
CARDIOVASCULAR DISEASE;
CEREBROVASCULAR ACCIDENT;
CLINICAL TRIAL;
DOSE RESPONSE;
DRUG BLOOD LEVEL;
DRUG CONTRAINDICATION;
DRUG INHIBITION;
DRUG METABOLISM;
DRUG SAFETY;
DRUG SYNTHESIS;
EXPERIMENTAL MODEL;
HUMAN;
NONHUMAN;
REVIEW;
STRUCTURE ACTIVITY RELATION;
THROMBOCYTE AGGREGATION INHIBITION;
THROMBOCYTOPENIA;
THROMBOEMBOLISM;
TRANSLUMINAL CORONARY ANGIOPLASTY;
ANIMALS;
ANTIBODIES, MONOCLONAL;
CLINICAL TRIALS, PHASE I;
CLINICAL TRIALS, PHASE II;
HUMANS;
PLATELET AGGREGATION INHIBITORS;
PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX;
STRUCTURE-ACTIVITY RELATIONSHIP;
VASCULAR DISEASES;
|
|
EID: 0034890735
PISSN: 09678298
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (7)
|
|
References (19)
|
